Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure

American Heart Journal

Volumn 150, Issue 1, 2005, Pages 137-143

  Lamblin, Nicolas ^a,c   Susen, Sophie ^a,b   Dagorn, Joël ^a   Mouquet, Frédéric ^a   Jude, Brigitte ^a,b   Van Belle, Eric ^a,b   Bauters, Christophe ^a,c   De Groote, Pascal ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYTOKINE; SCATTER FACTOR; VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

FEMALE; HEART FAILURE, CONGESTIVE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 23244445741     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.047     Document Type: Article

References (26)

1. J.N. Cohn, R. Ferrari, and N. Sharpe Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 2000 569 582
2. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
3. K. Matsumoto, and T. Nakamura Emerging multipotent aspects of hepatocyte growth factor J Biochem 119 1996 591 600
4. K. Ono, A. Matsumori, and T. Shioi Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model Circulation 95 1997 2552 2558
5. T. Nakamura, S. Mizuno, and K. Matsumoto Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF J Clin Invest 106 2000 1511 1519
6. Y. Taniyama, R. Morishita, and M. Aoki Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy Hypertension 40 2002 47 53
7. Y. Li, G. Takemura, and K. Kosai Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice Circulation 107 2003 2499 2506
8. V. Jayasankar, Y.J. Woo, and L.T. Bish Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure Circulation 108 Suppl. 1 2003 II230 II236
9. C. Bauters, T. Asahara, and L.P. Zheng Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb Am J Physiol 267 1994 H1263 H1271
10. D. Abraham, R. Hofbauer, and R. Schafer Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy Circ Res 87 2000 644 647
11. A. Matsumori, Y. Furukawa, and T. Hashimoto Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction Biochem Biophys Res Commun 221 1996 391 395
12. S. Ueno, U. Ikeda, and Y. Hojo Serum hepatocyte growth factor levels are increased in patients with congestive heart failure J Card Fail 7 2001 329 334
13. B.S. Chin, N.A. Chung, and C.R. Gibbs Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure Am J Cardiol 90 2002 1258 1260
14. T. Taniguchi, M. Toi, and T. Tominaga Rapid induction of hepatocyte growth factor by heparin Lancet 344 1994 470
15. P. de Groote, J. Dagorn, and B. Soudan B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure J Am Coll Cardiol 43 2004 1584 1589
16. G.Y. Xie, M.R. Berk, and M.D. Smith Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure J Am Coll Cardiol 24 1994 132 139
17. G.H. Mudge, S. Goldstein, and L.J. Addonizio 24th Bethesda conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization J Am Coll Cardiol 22 1993 21 31
18. R.L. Woodbury, S.M. Varnum, and R.C. Zangar Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA J Proteome Res 1 2002 233 237
19. C. Nieder, N. Andratschke, and B. Jeremic Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer Anticancer Res 23 2003 5117 5123
20. Y. Hojo, U. Ikeda, and Y. Zhu Expression of vascular endothelial growth factor in patients with acute myocardial infarction J Am Coll Cardiol 35 2000 968 973
21. K. Matsumoto, H. Tajima, and M. Hamanoue Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor Proc Natl Acad Sci U S A 89 1992 3800 3804
22. T. Gustafsson, K. Bodin, and C. Sylven Increased expression of VEGF following exercise training in patients with heart failure Eur J Clin Invest 31 2001 362 366
23. E. Van Belle, B. Witzenbichler, and D. Chen Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis Circulation 97 1998 381 390
24. D.M. Mancini, H. Eisen, and W. Kussmaul Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
25. J.N. Cohn, G.R. Johnson, and R. Shabetai Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI5 VI16
26. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 328